PLUS THERAPEUTICS, INC. (PSTV) Return on equity 2016–2025
PLUS THERAPEUTICS, INC. (PSTV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-560.2%FY2025 · since FY2016: -200.7% → -560.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -560.2% | — |
| FY2018 | -241.8% | -67.3 pp |
| FY2017 | -174.5% | +26.2 pp |
| FY2016 | -200.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice